References for this Review were identified by searches of PubMed from 1966 until January, 2008, with the terms “ischaemic” or “ischemic” and “stroke” and “infection”. Articles were also identified through searches of the authors' own files. Only articles published in English were reviewed. Articles about the association between HIV infection and stroke were excluded; a comprehensive discussion of HIV-associated stroke was deemed to be beyond the scope of the present Review.
ReviewAcute ischaemic stroke and infection: recent and emerging concepts
Introduction
There is considerable interest in the role of inflammatory mechanisms in ischaemic stroke. Much of this interest has focused on CNS and peripheral inflammatory responses to cerebral ischaemic injury and the identification of suitable targets in the inflammatory cascade for intervention. However, inflammation also includes important aspects of the host immune response to infection. The occurrence of infection, whether preceding or following ischaemic stroke, is becoming well recognised and is accompanied by an expansion in the literature in recent years. This has led to experimental and clinical developments in our understanding of how acute infection can trigger stroke and how preceding infection can influence outcome. Simultaneously, there has been progress in understanding the risk of poststroke infection, including the emerging concept of brain-induced immunodepression and how this might affect clinical outcome. Improvements in our understanding of preceding and poststroke infection are also important in terms of current and emerging treatment strategies for ischaemic stroke. The aim of this Review is to present a coherent account of the association between infection before or after acute ischaemic stroke and the implications for treatment by bringing together evidence from clinical and experimental studies.
Section snippets
Chronic infection and conventional stroke risk factors
The capacity of chronic infections to induce inflammation in tissues might provide a link to the progression of atherosclerotic plaques.1, 2, 3 Prospective seroepidemiological studies could help to establish potential causal links between particular chronic infections and stroke, although the contribution to overall stroke risk might be small.4 However, a range of infections can increase risk when associated with conventional stroke risk factors and genetic predisposition.2 As with acute
Frequency of poststroke infection
The frequency of poststroke infection has been the focus of several studies (table 2),49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69 which have been done in various settings, including developing and developed countries. Direct comparisons between these studies is difficult when factors such as differences in study design, selection bias, setting, location, definition of infections, and poststroke reporting interval are taken into account. The studies also
Preceding infection
The recognition that vulnerable individuals might have a short-term increased risk of stroke in association with acute systemic infection could have important implications for clinical practice. There is no evidence to support targeting more intensive stroke prevention strategies to patients with a history of stroke or risk factors for stroke during acute infections, but this is an interesting and important area for future study. Emphasising the importance of compliance in patients already on
Conclusions
The associations between infection and acute ischaemic stroke are complex (figure 2). Acute infection is an important trigger for stroke; the reported prevalence of infection in the week preceding stroke ranges from 10–35%, during which time infection confers at least a 2–3-times increased risk of stroke. Possible mechanisms include changes in atherosclerotic plaque stability, alterations in immunohaematological mechanisms, proinflammatory cytokine activation, platelet activation, and
Search strategy and selection criteria
References (106)
- et al.
Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis
Lancet Neurol
(2007) - et al.
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease
Lancet
(1994) - et al.
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
Blood
(1993) - et al.
Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness
J Thromb Haemost
(2005) - et al.
Leukocyte count is associated with reduced endothelial reactivity
Atherosclerosis
(2005) - et al.
An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis
J Neuroimmunol
(2003) - et al.
Ischemic tolerance and endogenous neuroprotection
Trends Neurosci
(2003) - et al.
Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats
Brain Res
(1997) - et al.
Proinflammatory cytokines: indicators of infection in high-risk patients
J Lab Clin Med
(1997) - et al.
Fever and infection early after ischemic stroke
J Neurol Sci
(1999)